Universal- Beteiligungs- und Servicegesellschaft mbH
Position in ABT — Abbott Laboratories
CIK 2057170
FRANKFURT AM MAIN, 2M
Position in ABT
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$129,947,029
-$15,218,700 QoQ
Shares Held
1,432,081
+1.3% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#108
of 2,959 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 93%
Shared 7%
None 0%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Universal- Beteiligungs- und Servicegesellschaft mbH holds $793,570,202 across 37 Medical Devices names. ABT ranks #3 (16.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
488,231 | $153,714,648 | |
| 2 | EW |
Edwards Lifesciences Corp
|
1,551,434 | $140,342,719 | |
| 3 | ABT |
Abbott Laboratories
This page
|
1,432,081 | $129,947,029 | |
| 4 | MDT |
Medtronic plc
|
1,590,358 | $124,413,706 | |
| 5 | BSX |
Boston Scientific Corp
|
1,101,593 | $47,015,989 | |
| 6 | DXCM |
Dexcom Inc
|
584,004 | $39,332,669 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
591,581 | $37,867,099 | |
| 8 | PODD |
Insulet Corp
|
160,405 | $24,421,661 |
All Filings in ABT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $129,947,029 | 1,432,081 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $145,165,729 | 1,413,906 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $167,921,175 | 1,340,260 | Shares | Defined | 2026-01-28 | |
| 2025-09-30 | $199,802,718 | 1,491,733 | Shares | Defined | 2025-10-30 | |
| 2025-06-30 | $191,116,083 | 1,405,162 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $176,006,519 | 1,326,849 | Shares | Defined | 2025-05-06 | |
| 2024-12-31 | $158,118,844 | 1,397,921 | Shares | Defined | 2025-02-28 | |
| No filing history on record for this holder in this stock. | ||||||